First Header Logo Second Header Logo

Ashok Hemal

Concepts (418)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Robotics
89
2020
133
17.320
Why?
Nephrectomy
62
2020
123
13.030
Why?
Laparoscopy
68
2018
184
12.750
Why?
Kidney Neoplasms
49
2020
200
10.500
Why?
Cystectomy
44
2020
109
8.550
Why?
Urinary Bladder Neoplasms
37
2020
189
6.480
Why?
Urologic Surgical Procedures
28
2019
66
5.600
Why?
Prostatectomy
29
2019
85
5.450
Why?
Carcinoma, Transitional Cell
20
2018
67
4.550
Why?
Ureter
18
2018
39
4.090
Why?
Indocyanine Green
10
2019
14
3.560
Why?
Prostatic Neoplasms
29
2019
489
3.070
Why?
Postoperative Complications
34
2019
818
2.820
Why?
Kidney Pelvis
13
2018
17
2.760
Why?
Humans
214
2020
32284
2.760
Why?
Ureteral Neoplasms
8
2015
11
2.650
Why?
Ureteral Obstruction
12
2013
28
2.640
Why?
Male
163
2020
19434
2.620
Why?
Coloring Agents
7
2019
31
2.430
Why?
Carcinoma, Renal Cell
11
2019
113
2.420
Why?
Urinary Bladder
13
2018
320
2.400
Why?
Middle Aged
119
2020
11843
2.330
Why?
Aged
99
2020
10257
2.210
Why?
Treatment Outcome
71
2020
3410
2.080
Why?
Female
127
2020
19954
2.030
Why?
Lymph Node Excision
16
2018
94
1.960
Why?
Surgery, Computer-Assisted
9
2019
65
1.910
Why?
Kidney Calculi
10
2018
23
1.900
Why?
Urinary Diversion
12
2020
27
1.850
Why?
Adult
81
2019
9263
1.820
Why?
Kidney
15
2019
520
1.570
Why?
Aged, 80 and over
36
2019
3896
1.440
Why?
Prostatic Hyperplasia
5
2019
59
1.430
Why?
Retrospective Studies
48
2020
3612
1.400
Why?
Reconstructive Surgical Procedures
8
2012
191
1.380
Why?
Retroperitoneal Space
12
2018
20
1.160
Why?
Prospective Studies
25
2019
2320
1.150
Why?
Adrenalectomy
7
2016
33
1.130
Why?
Renal Insufficiency, Chronic
7
2019
293
1.090
Why?
Follow-Up Studies
30
2019
2238
1.070
Why?
Neoplasm Invasiveness
12
2019
180
1.060
Why?
Adrenal Gland Neoplasms
5
2016
17
1.020
Why?
Glomerular Filtration Rate
17
2020
302
0.990
Why?
Length of Stay
16
2019
321
0.980
Why?
Ureteral Calculi
4
2018
7
0.940
Why?
Lymphography
3
2014
4
0.930
Why?
Nomograms
4
2020
35
0.890
Why?
Ureteral Diseases
4
2018
8
0.870
Why?
Angiography
2
2014
76
0.810
Why?
Young Adult
19
2019
2652
0.800
Why?
Lymphatic Metastasis
4
2019
169
0.770
Why?
Carcinoma, Squamous Cell
2
2019
156
0.750
Why?
Feasibility Studies
16
2019
309
0.730
Why?
Neoplasm Staging
15
2018
458
0.730
Why?
Sutures
2
2011
19
0.680
Why?
Warm Ischemia
5
2020
9
0.680
Why?
Magnetic Resonance Spectroscopy
5
2009
93
0.680
Why?
Replantation
2
2013
15
0.670
Why?
Adolescent
22
2019
3521
0.670
Why?
Urinary Bladder Fistula
2
2012
2
0.660
Why?
Fistula
2
2012
10
0.660
Why?
Fluorescence
7
2016
22
0.640
Why?
Patient Positioning
4
2015
21
0.640
Why?
Pelvis
9
2018
67
0.640
Why?
Pheochromocytoma
3
2013
6
0.640
Why?
Stents
5
2018
159
0.620
Why?
Urologic Neoplasms
3
2019
13
0.610
Why?
Vesicovaginal Fistula
3
2010
4
0.600
Why?
Prostate
8
2013
88
0.580
Why?
Penile Neoplasms
1
2019
6
0.580
Why?
Adenocarcinoma
3
2013
298
0.580
Why?
Monitoring, Intraoperative
1
2019
40
0.570
Why?
Urologic Diseases
1
2019
35
0.570
Why?
Surgical Instruments
5
2012
25
0.550
Why?
Kidney Diseases
5
2016
242
0.550
Why?
Urogenital Surgical Procedures
2
2009
7
0.530
Why?
Lymph Nodes
5
2014
114
0.530
Why?
Renal Artery
6
2019
47
0.520
Why?
Child
16
2016
2446
0.520
Why?
Kidney Diseases, Cystic
3
2018
12
0.520
Why?
Risk Factors
18
2019
3938
0.490
Why?
Hemostasis, Surgical
1
2016
11
0.490
Why?
Urinary Tract
2
2015
31
0.470
Why?
Reperfusion Injury
1
2016
60
0.460
Why?
Proteinuria
1
2016
52
0.460
Why?
Blood Loss, Surgical
6
2018
50
0.460
Why?
Time Factors
12
2019
2196
0.450
Why?
Ureterostomy
3
2010
3
0.450
Why?
Urinary Catheterization
1
2015
22
0.450
Why?
Sarcopenia
1
2015
50
0.440
Why?
Ureteroscopy
3
2006
6
0.430
Why?
Perioperative Care
5
2018
51
0.430
Why?
Hysterectomy
4
2009
52
0.430
Why?
Clinical Competence
4
2013
329
0.420
Why?
Preoperative Period
5
2019
30
0.420
Why?
Prognosis
11
2018
1529
0.410
Why?
Neoplasm Recurrence, Local
4
2020
372
0.410
Why?
Survival Rate
8
2019
892
0.400
Why?
Cystostomy
2
2012
5
0.400
Why?
Infrared Rays
2
2016
16
0.400
Why?
Patient Selection
7
2019
272
0.390
Why?
Lymphoid Tissue
1
2013
11
0.390
Why?
Kidney Transplantation
3
2015
490
0.390
Why?
Urethra
4
2011
125
0.390
Why?
Program Evaluation
2
2011
171
0.390
Why?
Lymphocytes
1
2013
56
0.390
Why?
Adenoma
1
2013
35
0.380
Why?
Vesico-Ureteral Reflux
1
2013
22
0.380
Why?
Neutrophils
1
2013
120
0.370
Why?
Predictive Value of Tests
7
2019
880
0.370
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
167
0.370
Why?
Uterine Cervical Diseases
1
2012
2
0.370
Why?
Constriction
7
2019
14
0.360
Why?
Erectile Dysfunction
2
2018
69
0.360
Why?
Uremia
2
2011
9
0.350
Why?
Wound Healing
2
2010
180
0.350
Why?
Kidney Failure, Chronic
2
2019
532
0.350
Why?
Risk Assessment
11
2019
1424
0.340
Why?
Suture Techniques
1
2011
60
0.340
Why?
Intraoperative Care
1
2011
52
0.340
Why?
Cesarean Section
1
2012
114
0.340
Why?
Nephrostomy, Percutaneous
7
2016
17
0.330
Why?
Peritoneum
3
2018
32
0.330
Why?
Mononeuropathies
1
2010
2
0.330
Why?
Cystoscopy
4
2014
27
0.320
Why?
Urothelium
1
2011
64
0.320
Why?
Postoperative Period
4
2019
95
0.320
Why?
Disease Progression
4
2017
590
0.310
Why?
Forecasting
5
2019
144
0.310
Why?
Urinary Bladder Calculi
1
2010
2
0.310
Why?
Urinary Fistula
1
2009
2
0.310
Why?
Penis
2
2010
45
0.300
Why?
Drainage
3
2016
65
0.300
Why?
Pyonephrosis
1
2009
1
0.300
Why?
Survival Analysis
5
2018
478
0.300
Why?
Lower Extremity
1
2010
99
0.300
Why?
Uterine Diseases
1
2009
10
0.300
Why?
Urogenital System
1
2009
11
0.300
Why?
Cohort Studies
8
2019
1840
0.290
Why?
Intraoperative Complications
3
2019
55
0.290
Why?
Databases, Factual
6
2019
368
0.280
Why?
Equipment Design
5
2011
177
0.280
Why?
Exosomes
2
2019
43
0.270
Why?
Lithotripsy
5
2007
12
0.270
Why?
Urinary Incontinence
2
2019
68
0.270
Why?
Vena Cava, Inferior
3
2019
28
0.260
Why?
Anastomosis, Surgical
4
2011
58
0.260
Why?
Granuloma, Foreign-Body
2
2010
6
0.260
Why?
Propensity Score
5
2020
47
0.260
Why?
Ischemia
4
2019
115
0.250
Why?
Lymphangioma
1
2006
7
0.250
Why?
Urachus
1
2006
3
0.240
Why?
Carcinoma
2
2004
92
0.240
Why?
Postoperative Care
6
2018
79
0.240
Why?
Kidney Calices
1
2006
4
0.240
Why?
Penile Erection
1
2005
31
0.230
Why?
Severity of Illness Index
5
2019
851
0.230
Why?
Urography
4
2009
15
0.230
Why?
Multivariate Analysis
6
2018
650
0.230
Why?
Logistic Models
5
2019
743
0.220
Why?
Preoperative Care
4
2016
126
0.220
Why?
Emigrants and Immigrants
2
2016
198
0.210
Why?
Age Factors
3
2018
1179
0.210
Why?
Comorbidity
2
2017
563
0.210
Why?
Tuberculosis, Urogenital
1
2004
2
0.210
Why?
Postural Balance
1
2016
142
0.210
Why?
Epididymis
1
2004
8
0.210
Why?
Pesticides
1
2016
135
0.210
Why?
Occupational Exposure
1
2016
159
0.210
Why?
Infertility, Male
1
2004
24
0.210
Why?
Iliac Vein
1
2004
7
0.200
Why?
Transients and Migrants
1
2016
197
0.200
Why?
Prostate-Specific Antigen
5
2008
59
0.200
Why?
Apolipoproteins
2
2016
193
0.200
Why?
Lipoproteins, HDL
2
2016
247
0.190
Why?
Proportional Hazards Models
3
2015
773
0.190
Why?
Renal Insufficiency
3
2019
57
0.190
Why?
Vascular Surgical Procedures
1
2004
85
0.190
Why?
Magnetic Resonance Imaging
5
2009
1211
0.190
Why?
Adrenal Glands
1
2002
5
0.180
Why?
Tumor Suppressor Protein p53
1
2003
80
0.180
Why?
ROC Curve
4
2019
169
0.180
Why?
Renal Veins
3
2016
7
0.180
Why?
Disease-Free Survival
4
2019
322
0.180
Why?
Brain Neoplasms
2
2007
636
0.180
Why?
Radiography
2
2015
358
0.180
Why?
Sensitivity and Specificity
5
2014
555
0.180
Why?
Diagnosis, Differential
3
2013
502
0.180
Why?
Hispanic Americans
1
2016
772
0.170
Why?
United States
6
2019
4079
0.160
Why?
Candidiasis
1
2020
6
0.160
Why?
Pyelonephritis
1
2020
9
0.160
Why?
Gram-Positive Bacterial Infections
1
2020
13
0.160
Why?
Emphysema
1
2020
12
0.160
Why?
Urology
1
2020
33
0.150
Why?
Qa-SNARE Proteins
1
2019
6
0.150
Why?
Phenylthiohydantoin
1
2019
8
0.150
Why?
Neoadjuvant Therapy
1
2019
62
0.150
Why?
Thrombosis
1
2019
78
0.140
Why?
Tumor Virus Infections
1
2018
21
0.140
Why?
Chemotherapy, Adjuvant
1
2019
185
0.140
Why?
Polyomavirus Infections
1
2018
20
0.140
Why?
Antineoplastic Agents
2
2019
595
0.130
Why?
Endoscopy
1
2018
54
0.130
Why?
Neoplasms, Multiple Primary
2
2010
19
0.130
Why?
Hospital Costs
1
2018
48
0.130
Why?
Costs and Cost Analysis
2
2009
106
0.130
Why?
Incidence
4
2019
1244
0.130
Why?
Placenta
1
2018
74
0.130
Why?
Decision Support Techniques
1
2018
131
0.130
Why?
Reoperation
4
2019
247
0.130
Why?
Kidney Function Tests
2
2016
101
0.130
Why?
Probability
3
2007
154
0.130
Why?
Laparoscopes
2
2009
3
0.120
Why?
Mitochondrial Diseases
1
2016
11
0.120
Why?
Protective Agents
1
2016
3
0.120
Why?
Intraoperative Period
1
2016
43
0.120
Why?
Organ Size
2
2015
221
0.120
Why?
North Carolina
2
2016
1299
0.120
Why?
Models, Theoretical
1
2017
139
0.120
Why?
India
5
2008
65
0.120
Why?
Administration, Oral
1
2016
201
0.120
Why?
Urinary Calculi
2
2006
7
0.120
Why?
Drug Administration Schedule
1
2016
276
0.120
Why?
Hypertension
3
2019
983
0.120
Why?
Case-Control Studies
4
2018
858
0.110
Why?
Psoas Muscles
1
2015
16
0.110
Why?
Stem Cells
1
2018
317
0.110
Why?
Recurrence
4
2010
287
0.110
Why?
Double-Blind Method
1
2016
566
0.110
Why?
Risk
1
2016
305
0.110
Why?
Diabetes Mellitus
2
2018
390
0.110
Why?
Creatinine
2
2013
191
0.110
Why?
Premedication
1
2014
15
0.110
Why?
Mesangial Cells
1
2014
9
0.110
Why?
Reproducibility of Results
3
2018
755
0.100
Why?
Analysis of Variance
2
2013
470
0.100
Why?
Kidney Glomerulus
1
2014
28
0.100
Why?
Kidney Tubules, Proximal
1
2014
39
0.100
Why?
Thiazolidinediones
1
2014
46
0.100
Why?
Cyclic AMP Response Element-Binding Protein
1
2013
17
0.100
Why?
Neoplasm, Residual
1
2013
22
0.100
Why?
Hyperplasia
1
2013
36
0.100
Why?
Epinephrine
1
2013
44
0.100
Why?
Tumor Burden
1
2013
62
0.100
Why?
Combined Modality Therapy
4
2010
550
0.100
Why?
Pilot Projects
2
2013
554
0.100
Why?
Constriction, Pathologic
1
2013
45
0.090
Why?
Dissection
1
2012
16
0.090
Why?
Body Mass Index
1
2016
863
0.090
Why?
RNA, Messenger
1
2014
499
0.090
Why?
Urinary Tract Infections
1
2012
42
0.090
Why?
Obesity
1
2019
1108
0.090
Why?
African Americans
1
2018
1335
0.090
Why?
Patient Readmission
3
2019
135
0.090
Why?
Europe
3
2019
82
0.090
Why?
Pregnancy Complications
1
2012
109
0.090
Why?
Dioxanes
1
2011
6
0.080
Why?
Tomography, X-Ray Computed
3
2006
906
0.080
Why?
Biopsy
4
2014
249
0.080
Why?
Statistics, Nonparametric
1
2011
128
0.080
Why?
Ablation Techniques
1
2011
24
0.080
Why?
Polymers
1
2011
65
0.080
Why?
Polyesters
1
2011
76
0.080
Why?
Physicians
1
2013
163
0.080
Why?
Operating Rooms
1
2011
41
0.080
Why?
Mineral Oil
1
2010
4
0.080
Why?
Sclerosis
1
2010
9
0.080
Why?
Ganglioneuroma
1
2010
2
0.080
Why?
Paraganglioma
1
2010
5
0.080
Why?
Neurilemmoma
1
2010
17
0.080
Why?
Urolithiasis
2
2007
8
0.080
Why?
Cystotomy
1
2010
1
0.080
Why?
Algorithms
2
2011
537
0.080
Why?
Retroperitoneal Neoplasms
1
2010
19
0.080
Why?
Cost-Benefit Analysis
2
2016
191
0.080
Why?
Incidental Findings
1
2010
25
0.080
Why?
Catheter Ablation
1
2010
113
0.070
Why?
Mesocolon
1
2009
5
0.070
Why?
Pain Measurement
2
2007
340
0.070
Why?
Vaginal Fistula
1
2008
2
0.070
Why?
Biopsy, Needle
3
2005
93
0.070
Why?
Gynecologic Surgical Procedures
1
2009
47
0.070
Why?
Tissue Adhesions
1
2008
11
0.070
Why?
Nephrons
2
2018
10
0.070
Why?
Retreatment
1
2008
42
0.070
Why?
Animals
4
2018
8165
0.070
Why?
Anesthesia
1
2009
63
0.070
Why?
Urethral Stricture
1
2008
31
0.070
Why?
Seminal Vesicles
2
2005
3
0.070
Why?
Intubation, Gastrointestinal
1
2008
10
0.070
Why?
Developing Countries
1
2008
59
0.070
Why?
Program Development
1
2008
93
0.070
Why?
Receptor, erbB-2
1
2008
63
0.060
Why?
Fellowships and Scholarships
1
2008
51
0.060
Why?
Citric Acid
2
2005
6
0.060
Why?
Republic of Korea
2
2019
12
0.060
Why?
Cell Line, Tumor
2
2019
726
0.060
Why?
Carboplatin
1
2007
42
0.060
Why?
Surgical Procedures, Operative
1
2007
78
0.060
Why?
Punctures
1
2006
30
0.060
Why?
Paclitaxel
1
2007
57
0.060
Why?
Models, Economic
1
2006
18
0.060
Why?
Analgesics
1
2007
111
0.060
Why?
Citrates
1
2006
5
0.060
Why?
Urogenital Abnormalities
1
2006
3
0.060
Why?
Rare Diseases
1
2006
17
0.060
Why?
Diffusion Magnetic Resonance Imaging
1
2006
49
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2008
257
0.060
Why?
Software
1
2006
125
0.060
Why?
Flank Pain
1
2005
1
0.060
Why?
Child, Preschool
4
2016
1248
0.060
Why?
Adrenal Gland Diseases
1
2005
2
0.060
Why?
Pain, Postoperative
1
2007
198
0.060
Why?
Quality of Life
1
2011
971
0.060
Why?
Immunohistochemistry
2
2005
544
0.050
Why?
Flutamide
1
2004
4
0.050
Why?
Orchiectomy
1
2004
14
0.050
Why?
Pain
1
2007
303
0.050
Why?
Antineoplastic Agents, Hormonal
1
2004
40
0.050
Why?
Urinary Reservoirs, Continent
1
2004
3
0.050
Why?
Creatine
1
2003
5
0.050
Why?
Neoplastic Cells, Circulating
1
2004
23
0.050
Why?
Odds Ratio
2
2016
455
0.050
Why?
Protons
1
2003
22
0.050
Why?
Choline
1
2003
18
0.050
Why?
Vagina
1
2004
61
0.050
Why?
Uterus
1
2004
77
0.050
Why?
Disease Models, Animal
2
2018
1073
0.050
Why?
Cells, Cultured
2
2016
821
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2007
442
0.050
Why?
Equipment Reuse
1
2002
5
0.050
Why?
Pregnancy
2
2018
963
0.050
Why?
Physical Examination
2
2016
83
0.050
Why?
Unnecessary Procedures
1
2002
16
0.040
Why?
Muscle, Smooth
1
2003
152
0.040
Why?
Wounds and Injuries
1
2004
240
0.040
Why?
Swine
2
2016
229
0.040
Why?
Delayed Diagnosis
1
2020
18
0.040
Why?
Fatal Outcome
1
2020
86
0.040
Why?
Fear
1
2020
42
0.040
Why?
Muscles
1
2020
69
0.040
Why?
Ohio
1
2019
63
0.040
Why?
Drug Resistance, Neoplasm
1
2019
106
0.040
Why?
Infant
2
2016
1024
0.040
Why?
Retrospective Moral Judgment
1
2018
1
0.040
Why?
Demography
2
2010
101
0.040
Why?
JC Virus
1
2018
20
0.040
Why?
Sexual Behavior, Animal
1
2018
11
0.040
Why?
Chemokine CXCL12
1
2018
27
0.030
Why?
Imaging, Three-Dimensional
1
2019
132
0.030
Why?
Linear Models
1
2019
426
0.030
Why?
Urodynamics
1
2018
88
0.030
Why?
Diabetes Complications
1
2019
171
0.030
Why?
International Cooperation
1
2017
31
0.030
Why?
Recovery of Function
1
2019
236
0.030
Why?
Overweight
1
2019
252
0.030
Why?
Personnel Staffing and Scheduling
1
2017
16
0.030
Why?
Cell Survival
1
2018
286
0.030
Why?
Quality Control
1
2017
42
0.030
Why?
Genotype
1
2018
706
0.030
Why?
Evidence-Based Medicine
1
2018
212
0.030
Why?
Lipids
1
2018
250
0.030
Why?
Macaca fascicularis
1
2018
542
0.030
Why?
Treatment Failure
1
2016
164
0.030
Why?
Sex Factors
1
2018
656
0.030
Why?
Cell Proliferation
1
2018
599
0.030
Why?
Magnesium Compounds
2
2005
2
0.030
Why?
Calcium Oxalate
2
2005
3
0.030
Why?
African Continental Ancestry Group
1
2016
338
0.030
Why?
Phosphates
2
2005
26
0.030
Why?
Uric Acid
2
2005
26
0.030
Why?
Fascia
2
2005
9
0.030
Why?
Podocytes
1
2014
19
0.030
Why?
Signal Transduction
1
2018
716
0.030
Why?
Biomedical Research
1
2016
178
0.030
Why?
Microscopy, Fluorescence
1
2014
93
0.030
Why?
Gene Expression Regulation
1
2016
478
0.030
Why?
Epithelial Cells
1
2014
137
0.020
Why?
Cell Line
1
2014
443
0.020
Why?
Asia
1
2013
19
0.020
Why?
Phosphorylation
1
2013
248
0.020
Why?
Spectroscopy, Near-Infrared
1
2012
10
0.020
Why?
Gases
1
2012
3
0.020
Why?
Calcium Phosphates
1
2012
9
0.020
Why?
Hypoglycemic Agents
1
2014
186
0.020
Why?
Reference Values
1
2012
238
0.020
Why?
Research Design
1
2013
316
0.020
Why?
Laos
1
2010
3
0.020
Why?
Infusions, Subcutaneous
1
2010
4
0.020
Why?
Men's Health
1
2010
10
0.020
Why?
Practice Guidelines as Topic
1
2013
394
0.020
Why?
Ultrasonography, Interventional
1
2009
55
0.020
Why?
Iatrogenic Disease
1
2008
16
0.020
Why?
Age Distribution
1
2007
194
0.020
Why?
Drug Therapy, Combination
1
2007
293
0.020
Why?
Tissue Distribution
1
2006
64
0.010
Why?
Statistics as Topic
1
2006
99
0.010
Why?
Financing, Organized
1
2005
17
0.010
Why?
Professional Practice
1
2005
26
0.010
Why?
Apatites
1
2005
1
0.010
Why?
Powder Diffraction
1
2005
2
0.010
Why?
Fluoroscopy
1
2005
35
0.010
Why?
Convalescence
1
2004
2
0.010
Why?
Crystallography, X-Ray
1
2005
87
0.010
Why?
Education, Medical
1
2005
69
0.010
Why?
Critical Pathways
1
2004
47
0.010
Why?
Bone Neoplasms
1
2005
104
0.010
Why?
Tissue Donors
1
2005
185
0.010
Why?
Ileum
1
2004
16
0.010
Why?
Michigan
1
2003
3
0.010
Why?
Calcium
1
2005
337
0.010
Why?
Lung Neoplasms
1
2005
422
0.010
Why?
Ultrasonography
1
2004
394
0.010
Why?
Needs Assessment
1
2002
78
0.010
Why?
Cross-Sectional Studies
1
2005
1485
0.010
Why?
Mass Screening
1
2003
256
0.010
Why?
Registries
1
2002
294
0.010
Why?
Hemal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (418)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_